INSP: Inspire Medical Systems, Inc. Stock

by  •  • Comments Off on INSP: Inspire Medical Systems, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 4,707.98
Enterprise Value ($M) 4,557.83
Book Value ($M) 689.70
Book Value / Share 23.18
Price / Book 6.83
NCAV ($M) 512.12
NCAV / Share 17.21
Price / NCAV 9.19

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.08
Return on Equity (ROE) 0.09

Liquidity (mrq)
Quick Ratio 6.22
Current Ratio 7.13

Balance Sheet (mrq) ($M)
Current Assets 630.81
Assets 808.38
Liabilities 118.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 802.80
Operating Income 36.08
Net Income 53.51
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 130.25
Cash from Investing -113.12
Cash from Financing -52.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 8.30 -14.58
10-07 13G/A BlackRock, Inc. 13.80
10-04 13G/A Vanguard Group Inc 10.83 10.26

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-10 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PUR
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Sep
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Jun
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Mar

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-25 101,510 270,160 37.57
2025-04-24 135,320 310,205 43.62
2025-04-23 126,477 310,915 40.68
2025-04-22 115,006 263,361 43.67

(click for more detail)

Similar Companies
GKOS – Glaukos Corporation GMED – Globus Medical, Inc.
HAE – Haemonetics Corporation ITGR – Integer Holdings Corporation
MDT – Medtronic plc


Financial data and stock pages provided by
Fintel.io